Can DES Improve Diabetic Outcomes? Cardiologists Turn FREEDOM Fighters
This article was originally published in The Gray Sheet
Executive Summary
Drug-eluting stent trial and registry data suggest the technology is catching up with bypass surgery in reducing repeat revascularizations in diabetics, but researchers await clarity on the most elusive endpoint of all - survival